Eversheds comments on Department of Health scheme to reduce price of prescription drugs

Eversheds has commented on the UK Department of Health’s new scheme that is designed to reduce the price of prescription drugs, saying that it should be a good outcome for UK industry and the government alike.

Simon Crossley, pharmaceutical industry expert at Eversheds, said: ‘This new deal represents the end of a period of uncertainty and tough negotiation between the industry and British government as national health bodies across Europe seek to reduce the public cost of health provision amid continuing economic difficulties and austerity.

‘The new PPRS [Pharmaceutical Price Regulation Scheme] should represent a good outcome for both stakeholders with the government securing savings to the UK’s drugs bill and the pharmaceutical industry avoiding the prospect of an enforced regime had agreement not been reached.’